Magnazide TZ 250mg/31.25mg Injection
Marketer
Ikon Remedies Pvt Ltd
Salt Composition
Ceftazidime (250mg) + Tazobactum (31.25mg)
Overview Magnazide TZ 250mg/31.25mg Injection
Tazobactam and Ceftazidime injection (250mg/31.25mg) is a dual-action antibiotic used to combat diverse bacterial infections. This medication inhibits bacterial growth, thus curbing infection spread. Administration should always be under a doctor's direct guidance. Strict adherence to the prescribed dosage schedule is crucial; completing the full course is vital, even with symptom improvement. Premature cessation may compromise its effectiveness. Potential side effects include, but aren't limited to, nausea, vomiting, diarrhea, and dyspepsia. Severe or persistent side effects necessitate immediate medical attention. Seek immediate medical help for allergic reactions (e.g., skin rashes, itching, swelling, respiratory distress). Inform your physician of all current medications, especially if pregnant or breastfeeding, before commencing treatment. Alcohol consumption should be avoided due to potential increased drowsiness. While generally not impairing driving ability, refrain from driving if drowsiness or dizziness occurs. Adequate rest, a balanced diet, and proper hydration contribute to faster recovery. Your physician may order blood tests and other assessments to monitor treatment efficacy.
Uses of Magnazide TZ 250mg/31.25mg Injection
Infections caused by bacteria
Major Benefits of Magnazide TZ 250mg/31.25mg Injection:
This medication will be administered by your physician or their designated nurse; self-medication is strictly prohibited.
Common Side effects of Magnazide TZ 250mg/31.25mg Injection:
- Nausea
- Vomiting
- Diarrhea
- Stomach pain
- Increased liver enzymes
- Allergic reaction
How to use Magnazide TZ 250mg/31.25mg Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
How Magnazide TZ 250mg/31.25mg Injection works:
Ceftazidime/Tazobactam injection (Magnazide TZ 250mg/31.25mg) combines the antibiotic Ceftazidime with the beta-lactamase inhibitor Tazobactam. Ceftazidime's mechanism involves disrupting bacterial cell wall synthesis, vital for bacterial viability. Tazobactam counters bacterial resistance, thereby optimizing Ceftazidime's antibacterial effect.
SAFETY ADVICE
AlcoholSAFE
Ingesting alcohol alongside Magnazide TZ 250mg/31.25mg Injection presents no known adverse reactions.
PregnancySAFE IF PRESCRIBED
Pregnancy use of Magnazide TZ 250mg/31.25mg Injection is typically deemed safe. Preclinical trials in animals revealed minimal or no harm to offspring; nevertheless, data from human trials are scarce.
Breast feedingSAFE IF PRESCRIBED
Injection of Magnazide TZ, containing 250mg/31.25mg, is considered safe for breastfeeding mothers. Research in humans indicates minimal drug transfer to breast milk, posing no apparent risk to the infant.
DrivingUNSAFE
Administering Magnazide TZ 250mg/31.25mg Injection might cause drowsiness, visual impairment, or dizziness. Refrain from operating a vehicle if such effects manifest.
KidneyCAUTION
Patients with impaired renal function should exercise caution when using Magnazide TZ 250mg/31.25mg Injection. Dosage modification may be necessary; physician consultation is advised.
LiverCAUTION
Patients with severe hepatic impairment should use Magnazide TZ 250mg/31.25mg Injection cautiously, as dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Magnazide TZ 250mg/31.25mg Injection :
Omit a dose of Magnazide TZ 250mg/31.25mg Injection? Seek your physician's advice.
Facts to Know About Magnazide TZ 250mg/31.25mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Antimicrobial Agents |
3,018 People bought this recently